Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-IMODE: Impact of Intraoperative Midazolam on Delirium Outcome of Elderly Patients
NCT06963112Phase 1Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Sep 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midazolam in delirium and anxiety disorder (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Incidence of postoperative delirium and Incidence of postoperative anxiety. Started Sep 2025; status: completed.
02
Drugs
midazolam
03
Conditions
deliriumanxiety disorder
Beyond the preview
Go deeper on NCT06963112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06963112.